These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 18408102

  • 1. Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis.
    Beraza N, Malato Y, Vander Borght S, Liedtke C, Wasmuth HE, Dreano M, de Vos R, Roskams T, Trautwein C.
    Gut; 2008 May; 57(5):655-63. PubMed ID: 18408102
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ, Yeh MM, Van Rooyen DM, Brooling J, Ghatora K, Farrell GC.
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [Abstract] [Full Text] [Related]

  • 3. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ, Yeh MM, Cheng J, Williams J, Brown S, dela Pena A, Bell-Anderson KS, Farrell GC.
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [Abstract] [Full Text] [Related]

  • 4. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
    Cong WN, Tao RY, Tian JY, Liu GT, Ye F.
    Life Sci; 2008 May 07; 82(19-20):983-90. PubMed ID: 18417155
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator.
    Yu J, Ip E, Dela Peña A, Hou JY, Sesha J, Pera N, Hall P, Kirsch R, Leclercq I, Farrell GC.
    Hepatology; 2006 Apr 07; 43(4):826-36. PubMed ID: 16557554
    [Abstract] [Full Text] [Related]

  • 8. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.
    Kawaguchi K, Sakaida I, Tsuchiya M, Omori K, Takami T, Okita K.
    Biochem Biophys Res Commun; 2004 Feb 27; 315(1):187-95. PubMed ID: 15013444
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Silibinin modulates lipid homeostasis and inhibits nuclear factor kappa B activation in experimental nonalcoholic steatohepatitis.
    Salamone F, Galvano F, Cappello F, Mangiameli A, Barbagallo I, Li Volti G.
    Transl Res; 2012 Jun 27; 159(6):477-86. PubMed ID: 22633099
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Alpha-lipoic acid attenuates methionine choline deficient diet-induced steatohepatitis in C57BL/6 mice.
    Min AK, Kim MK, Kim HS, Seo HY, Lee KU, Kim JG, Park KG, Lee IK.
    Life Sci; 2012 Jan 30; 90(5-6):200-5. PubMed ID: 22154902
    [Abstract] [Full Text] [Related]

  • 13. Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Staels B, Rubenstrunk A, Noel B, Rigou G, Delataille P, Millatt LJ, Baron M, Lucas A, Tailleux A, Hum DW, Ratziu V, Cariou B, Hanf R.
    Hepatology; 2013 Dec 30; 58(6):1941-52. PubMed ID: 23703580
    [Abstract] [Full Text] [Related]

  • 14. Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats.
    Imarisio C, Alchera E, Sutti S, Valente G, Boccafoschi F, Albano E, Carini R.
    Clin Sci (Lond); 2012 Sep 30; 123(5):323-32. PubMed ID: 22439844
    [Abstract] [Full Text] [Related]

  • 15. Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome.
    Ezquer M, Ezquer F, Ricca M, Allers C, Conget P.
    J Hepatol; 2011 Nov 30; 55(5):1112-20. PubMed ID: 21356258
    [Abstract] [Full Text] [Related]

  • 16. NF-κB1 deficiency stimulates the progression of non-alcoholic steatohepatitis (NASH) in mice by promoting NKT-cell-mediated responses.
    Locatelli I, Sutti S, Vacchiano M, Bozzola C, Albano E.
    Clin Sci (Lond); 2013 Feb 30; 124(4):279-87. PubMed ID: 22970906
    [Abstract] [Full Text] [Related]

  • 17. Anti-inflammatory effect of genistein on non-alcoholic steatohepatitis rats induced by high fat diet and its potential mechanisms.
    Ji G, Yang Q, Hao J, Guo L, Chen X, Hu J, Leng L, Jiang Z.
    Int Immunopharmacol; 2011 Jun 30; 11(6):762-8. PubMed ID: 21320636
    [Abstract] [Full Text] [Related]

  • 18. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice.
    Nan YM, Fu N, Wu WJ, Liang BL, Wang RQ, Zhao SX, Zhao JM, Yu J.
    Scand J Gastroenterol; 2009 Jun 30; 44(3):358-65. PubMed ID: 18991162
    [Abstract] [Full Text] [Related]

  • 19. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, Kathirvel E, French SW, Morgan TR.
    Eur J Gastroenterol Hepatol; 2008 Sep 30; 20(9):843-54. PubMed ID: 18794597
    [Abstract] [Full Text] [Related]

  • 20. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
    Yalniz M, Bahcecioglu IH, Kuzu N, Poyrazoglu OK, Bulmus O, Celebi S, Ustundag B, Ozercan IH, Sahin K.
    J Gastroenterol Hepatol; 2007 Nov 30; 22(11):2009-14. PubMed ID: 17914984
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.